Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Clinical Breast Cancer|November 20, 2025
Adherence to Multidisciplinary Tumor Board (MTB) Recommendations in Patients With Breast Cancer: The Results From Two Cancer Centers in GermanyEsin Aysel Kandemir, Rebekka Adam, Julia Roeper, et al.
JAMA Network Open|May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung CancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Nature Communications|June 17, 2022
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
The Oncologist|September 11, 2015
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR InhibitorsDavid F Heigener, Christian Schumann, Martin Sebastian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2016
A Novel EGFR(C797) Variant Detected in a Pleural Biopsy Specimen from an Osimertinib-Treated Patient Using a Comprehensive Hybrid Capture-Based Next-Generation Sequencing AssayRoopika Menon, Judith Müller, Petra Schneider, et al.
Oncology Research and Treatment|December 18, 2022
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022Friederike C Althoff, Toki A Bolt, Maximilian Rost, et al.
Genes, Chromosomes & Cancer|July 8, 2005
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemiaFrank Griesinger, Heike Hennig, Frauke Hillmer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2026
Real-world evidence of the impact of guideline concordance on survival in non-small cell lung cancerThomas Elter, Ursula Marschall, Patrizia Maria Maier, et al.
Clinical Lung Cancer|May 11, 2023
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)Nikolaj Frost, Annalen Bleckmann, Frank Griesinger, et al.
Cancers|November 13, 2025
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung CancerRike Geiken-Weinstock, Frank Griesinger, Michael Metz, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Clinical Breast Cancer|November 20, 2025
Adherence to Multidisciplinary Tumor Board (MTB) Recommendations in Patients With Breast Cancer: The Results From Two Cancer Centers in GermanyEsin Aysel Kandemir, Rebekka Adam, Julia Roeper, et al.
JAMA Network Open|May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung CancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
Nature Communications|June 17, 2022
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
The Oncologist|September 11, 2015
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR InhibitorsDavid F Heigener, Christian Schumann, Martin Sebastian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2016
A Novel EGFR(C797) Variant Detected in a Pleural Biopsy Specimen from an Osimertinib-Treated Patient Using a Comprehensive Hybrid Capture-Based Next-Generation Sequencing AssayRoopika Menon, Judith Müller, Petra Schneider, et al.
Oncology Research and Treatment|December 18, 2022
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022Friederike C Althoff, Toki A Bolt, Maximilian Rost, et al.
Genes, Chromosomes & Cancer|July 8, 2005
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemiaFrank Griesinger, Heike Hennig, Frauke Hillmer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2026
Real-world evidence of the impact of guideline concordance on survival in non-small cell lung cancerThomas Elter, Ursula Marschall, Patrizia Maria Maier, et al.
Clinical Lung Cancer|May 11, 2023
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)Nikolaj Frost, Annalen Bleckmann, Frank Griesinger, et al.
Cancers|November 13, 2025
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung CancerRike Geiken-Weinstock, Frank Griesinger, Michael Metz, et al.
Pageof 16